Extracorporeal Membrane Oxygenation Machine Market Research Report: Information by Component (Pumps, Oxygenators, Cannula and others), Modality, Application and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Global Forecast till 2027
ID: MRFR/HC/6647-HCR | February 2021 | Region: Global | 95 pages
Market Scenario
The global Extracorporeal Membrane Oxygenation Machine Market is expected to register a CAGR of 4.8% during the forecast period of 2019 to 2025 with a market value of USD 267.60 million in 2018.
Extracorporeal membrane oxygenation is a machine that provides cardiac and respiratory support for those patients whose heart and lungs are unable to provide an adequate supply of gas exchange to the body. It is also known as a life support machine. People who are suffering from a severe and life-threatening illness needs extracorporeal membrane oxygenation machine to carry out proper functioning of heart and lungs. The global extracorporeal membrane oxygenation machine market is driven by factors such as the growing prevalence of cardiovascular and respiratory diseases, rising adoption of the ECMO machine for lung transplantation, and the growing number of ECMO centers. Additionally, the rising prevalence of lung diseases coupled with increasing geriatric population is anticipated to fuel the market growth. As there is an increasing prevalence of lung and heart diseases, the demand for extracorporeal membrane oxygenation machine is also rising nowadays. As per the survey carried out by World Health Organization in 2017, around 306 hospitals in the US have ECMO machine for treatment of heart and lung diseases that are around 9385 ECMO devices were administered in US hospitals in 2017.
On the other hand, the complications associated with extracorporeal membranes oxygenation machines such as bleeding, infections, and technical failures are projected to hamper the growth of the market during the assessment period.
Segmentation
The global extracorporeal membrane oxygenation machine market has been segmented based on component, modality, application, and region.
The market, based on component, has been divided into pumps, oxygenators, controllers, cannula,
and accessories. The oxygenators segment is expected to hold a major share in the market due to the rising prevalence of lung diseases and increasing adoption of extracorporeal membrane oxygenation machine for cardiac treatments. The pumps segment is anticipated to be the fastest-growing as these are most widely used in the treatment of asthma.
The market based on modality is further segmented into veno-arterial (VA), veno-venous (VV), and arterio-venous (AV). The veno-arterial segment is expected to hold a major share in the market due to its widespread use in the treatment of cardiovascular collapse. Whereas veno-venous segment is expected to be the fastest-growing due to its increasing use in cardiogenic shock.
The market based on application is further segmented into respiratory, cardiac, and extracorporeal cardiopulmonary resuscitation (ECPR). The respiratory segment is expected to hold the major share in the market due to its crucial role in supporting pulmonary function and is projected to witness lucrative growth over the forecast period whereas the extracorporeal cardiopulmonary resuscitation segment is expected to be the fastest-growing due to the rising incidence of cardiac illness worldwide.
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The extracorporeal membrane oxygenation machine market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European extracorporeal membrane oxygenation machine market has been sub-divided into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, UK, Italy, Spain, and the rest of Western Europe. The extracorporeal membrane oxygenation machine market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The extracorporeal membrane oxygenation machine market in the Middle East & Africa has been divided into the Middle East and Africa.
Key Players
- Getinge Group
- Medtronic
- Livanova PLC
- Abbott
- Agilent Technologies
- Siemens AG
- Terumo Corporation
- Fresenius Medical Care AG & Co. KGaA
- Microport Scientific Corporation
- Nipro Corporation
- ALung Technologies, Inc.
- MAQUET Holding B.V. & Co. KG
- Medos Medizintechnik AG
- Terumo Cardiovascular Systems Corp
- Others
Regional Market Summary
Global Extracorporeal Membrane Oxygenation Machine Market Share, by Region, 2018 (%) 
Source: World Health Organization (WHO)
The market in the Americas is expected to dominate the global extracorporeal membrane oxygenation machine market due to the rising incidence of lung cancer, favorable reimbursement scenario, and increasing investment in research and development of new medical devices. As there is a rising prevalence of lung cancer in the US, the demand for extracorporeal membrane oxygenation machine is also increasing in this region. As per the survey carried out by the America Lung Association in 2017, around 11 million people are diagnosed with COPD in the US every year. High cases of COPD in the US and Canada is expected to drive the market growth.
The market in Europe showed a substantial amount of growth. This can be attributed to the presence of a well-established healthcare system, an increase in chronic diseases, and the involvement of key companies. As per the Luce Report on Lung Cancer 2016, around 312,000 people in Europe have lung cancer. As there is an increasing prevalence of lung cancer in this region, the demand for extracorporeal membrane oxygenation machine is also growing. Therefore, the market is expected to grow during the forecast period.
The market in Asia-Pacific is projected to be the fastest-growing over the forecast period owing to the rising prevalence of lung cancer in countries such as India and China. According to National Cancer Center (NCC) Report 2018, out of a total population around 35.1%, people are diagnosed with lung cancer every year in China and is one of the leading cause of deaths in this country.
The market in the Middle East & Africa is projected to account for the least share of the global extracorporeal membrane oxygenation machine market due to low disposable income in the region.
Global Extracorporeal Membrane Oxygenation Machine Market, by Component
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
Global Extracorporeal Membrane Oxygenation Machine Market, by Modality
- Veno-Arterial (VA)
- Veno-Venous (VV)
- Arterio-Venous (AV)
Global Extracorporeal Membrane Oxygenation Machine Market, by Application
- Respiratory
- Cardiac
- Extracorporeal Cardiopulmonary Resuscitation (ECPR)
Global Extracorporeal Membrane Oxygenation Machine Market, by Region
- Americas
- North America
- US
- Canada
- Latin America
- North America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Western Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
Intended Audience
- Research and development (R&D) companies
- Medical device companies
- Government research institutes
- Academic institutes and universities
- Venture capitalists
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | 2025: Significant Value |
| CAGR | 4.8% (2019-2025) |
| Base Year | 2019 |
| Forecast Period | 2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Component, Modality, Application |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Getinge Group, Medtronic, Livanova PLC, Abbott, Agilent Technologies, Siemens AG, Terumo Corporation, Fresenius Medical Care AG & Co. KGaA, Microport Scientific Corporation, Nipro Corporation, ALung Technologies, Inc., MAQUET Holding B.V. & Co. KG, Medos Medizintechnik AG, Terumo Cardiovascular Systems Corp |
| Key Market Opportunities | Increasing investment in research and development of new medical devices |
| Key Market Drivers | The increasing prevalence of cardiovascular concerns |
Frequently Asked Questions (FAQ) :
global market was valued at 267.6 million in 2018.
Extracorporeal Membrane Oxygenation Machine (ECMO) Marketis expected to exhibit a solid 4.8% CAGR over the forecast period from 2019 to 2025.
The increasing prevalence of cardiovascular concerns is the major driver for the global extracorporeal membrane oxygenation machine market.
The Americas market is expected to hold the largest share in the market.
Leading players in the extracorporeal membrane oxygenation machine market include Getinge Group, Agilent, Abbott, and Siemens, among others.
Table of Contents
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Extracorporeal Membrane Oxygenation Machine Market, by Component
6.1 Introduction
6.2 Pumps
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3 Oxygenators
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.4 Controllers
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.5 Cannula
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.6 Accessories
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 7. Global Extracorporeal Membrane Oxygenation Machine Market, by Modality
7.1 Introduction
7.2 Veno-Arterial (VA)
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3 Veno-Venous (VV)
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4 Arterio-Venous (AV)
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 8. Global Extracorporeal Membrane Oxygenation Machine Market, by Application
8.1 Introduction
8.2 Respiratory
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.3 Cardiac
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.4 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 9. Global Extracorporeal Membrane Oxygenation Machine Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 Latin America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
Chapter 11. Company Profiles
11.1 Getinge Group
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Medtronic
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Livanova PLC
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Abbott
11.4.1 Company Overview
11.4.2 Technology/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Agilent Technologies
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Siemens AG
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Terumo Corporation
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Fresenius Medical Care AG & Co. KGaA
11.8.1 Overview
11.8.2 Product/ Technology Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Microport Scientific Corporation
11.9.1 Overview
11.9.2 Product Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Nipro Corporation
11.10.1 Overview
11.10.2 Product Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 ALung Technologies, Inc
11.11.1 Overview
11.11.2 Product Overview
11.11.3 Financials
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.12 MAQUET Holding B.V. & Co. KG
11.12.1 Overview
11.12.2 Product Overview
11.12.3 Financials
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.13 Medos Medizintechnik AG
11.13.1 Overview
11.13.2 Product Overview
11.13.3 Financials
11.13.4 Key Developments
11.13.5 SWOT Analysis
11.14 Terumo Cardiovascular Systems Corp
11.14.1 Overview
11.14.2 Product Overview
11.14.3 Financials
11.14.4 Key Developments
11.14.5 SWOT Analysis
11.15 Others
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s Viewpoint
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
Chapter 13. Appendix
LIST OF TABLES
Table 1 Global Extracorporeal Membrane Oxygenation Machine Market Synopsis, 2020-2027
Table 2 Global Extracorporeal Membrane Oxygenation Machine Market Estimates and Forecast, 2020-2027(USD Million)
Table 3 Global Extracorporeal Membrane Oxygenation Machine Market, by Region, 2020-2027(USD Million)
Table 4 Global Extracorporeal Membrane Oxygenation Machine Market, by Components, 2020-2027(USD Million)
Table 5 Global Extracorporeal Membrane Oxygenation Machine Market, by Modality, 2020-2027(USD Million)
Table 6 Global Extracorporeal Membrane Oxygenation Machine Market, by Application, 2019- 2025 (USD Million)
Table 7 North America: Extracorporeal Membrane Oxygenation Machine Market, by Components, 2020-2027(USD Million)
Table 8 North America: Extracorporeal Membrane Oxygenation Machine Market, by Modality, 2020-2027(USD Million)
Table 9 North America: Extracorporeal Membrane Oxygenation Machine Market, by Application, 2020-2027(USD Million)
Table 10 US: Extracorporeal Membrane Oxygenation Machine Market, by Components, 2020-2027(USD Million)
Table 11 US: Extracorporeal Membrane Oxygenation Machine Market, by Modality, 2020-2027(USD Million)
Table 12 US: Extracorporeal Membrane Oxygenation Machine Market, by Application, 2020-2027(USD Million)
Table 13 Canada: Extracorporeal Membrane Oxygenation Machine Market, by Components, 2020-2027(USD Million)
Table 14 Canada: Extracorporeal Membrane Oxygenation Machine Market, by Modality, 2020-2027(USD Million)
Table 15 Canada: Extracorporeal Membrane Oxygenation Machine Market, by Application, 2020-2027(USD Million)
Table 16 Latin America: Extracorporeal Membrane Oxygenation Machine Market, by Components, 2020-2027(USD Million)
Table 17 Latin America: Extracorporeal Membrane Oxygenation Machine Market, by Modality, 2020-2027(USD Million)
Table 18 Latin America: Extracorporeal Membrane Oxygenation Machine Market, by Application, 2020-2027(USD Million)
Table 19 Europe: Extracorporeal Membrane Oxygenation Machine Market, by Components, 2020-2027(USD Million)
Table 20 Europe: Extracorporeal Membrane Oxygenation Machine Market, by Modality, 2020-2027(USD Million)
Table 21 Europe: Extracorporeal Membrane Oxygenation Machine Market, by Application, 2020-2027(USD Million)
Table 22 Western Europe: Extracorporeal Membrane Oxygenation Machine Market, by Components, 2020-2027(USD Million)
Table 23 Western Europe: Extracorporeal Membrane Oxygenation Machine Market, by Modality, 2020-2027(USD Million)
Table 24 Western Europe: Extracorporeal Membrane Oxygenation Machine Market, by Application, 2020-2027(USD Million)
Table 25 Eastern Europe: Extracorporeal Membrane Oxygenation Machine Market, by Components, 2020-2027(USD Million)
Table 26 Eastern Europe: Extracorporeal Membrane Oxygenation Machine Market, by Modality, 2020-2027(USD Million)
Table 27 Eastern Europe: Extracorporeal Membrane Oxygenation Machine Market, by Application, 2020-2027(USD Million)
Table 28 Asia-Pacific: Extracorporeal Membrane Oxygenation Machine Market, by Components, 2020-2027(USD Million)
Table 29 Asia-Pacific: Extracorporeal Membrane Oxygenation Machine Market, by Modality, 2020-2027(USD Million)
Table 30 Asia-Pacific: Extracorporeal Membrane Oxygenation Machine Market, by Application, 2020-2027(USD Million)
Table 31 Middle East & Africa: Extracorporeal Membrane Oxygenation Machine Market, by Components, 2020-2027(USD Million)
Table 32 Middle East & Africa: Extracorporeal Membrane Oxygenation Machine Market, by Modality, 2020-2027(USD Million)
Table 33 Middle East & Africa: Extracorporeal Membrane Oxygenation Machine Market, by Application, 2020-2027(USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Extracorporeal Membrane Oxygenation Machine Market
Figure 3 Segmentation Market Dynamics for Global Extracorporeal Membrane Oxygenation Machine Market
Figure 4 Global Extracorporeal Membrane Oxygenation Machine Market Share, by Components, 2020
Figure 5 Global Extracorporeal Membrane Oxygenation Machine Market Share, by Modality, 2020
Figure 6 Global Extracorporeal Membrane Oxygenation Machine Market Share, by Application, 2020
Figure 7 Global Extracorporeal Membrane Oxygenation Machine Market Share, by Region, 2020
Figure 8 North America: Extracorporeal Membrane Oxygenation Machine Market Share, by Country, 2020
Figure 9 Europe: Extracorporeal Membrane Oxygenation Machine Market Share, by Country, 2020
Figure 10 Asia-Pacific: Extracorporeal Membrane Oxygenation Machine Market Share, by Country, 2020
Figure 11 Middle East & Africa: Extracorporeal Membrane Oxygenation Machine Market Share, by Country, 2020
Figure 12 Global Extracorporeal Membrane Oxygenation Machine Market: Company Share Analysis, 2020 (%)
Figure 13 Getinge Group: Key Financials
Figure 14 Getinge Group: Segmental Revenue
Figure 15 Getinge Group: Geographical Revenue
Figure 16 Medtronic: Key Financials
Figure 17 Medtronic: Segmental Revenue
Figure 18 Medtronic: Geographical Revenue
Figure 19 Livanova PLC: Key Financials
Figure 20 Livanova PLC: Segmental Revenue
Figure 21 Livanova PLC: Geographical Revenue
Figure 22 Abbott: Key Financials
Figure 23 Abbott: Segmental Revenue
Figure 24 Abbott: Geographical Revenue
Figure 25 Agilent Technologies: Key Financials
Figure 26 Agilent Technologies: Segmental Revenue
Figure 27 Agilent Technologies: Geographical Revenue
Figure 28 Siemens AG: Key Financials
Figure 29 Siemens AG: Segmental Revenue
Figure 30 Siemens AG: Geographical Revenue
Figure 31 Terumo Corporation: Key Financials
Figure 32 Terumo Corporation: Segmental Revenue
Figure 33 Terumo Corporation: Geographical Revenue
Figure 34 Fresenius Medical Care AG & Co. KGaA: Key Financials
Figure 35 Fresenius Medical Care AG & Co. KGaA: Segmental Revenue
Figure 36 Fresenius Medical Care AG & Co. KGaA: Geographical Revenue
Figure 37 Microport Scientific Corporation: Key Financials
Figure 38 Microport Scientific Corporation: Segmental Revenue
Figure 39 Microport Scientific Corporation: Geographical Revenue
Figure 40 Nipro Corporation: Key Financials
Figure 41 Nipro Corporation: Segmental Revenue
Figure 42 Nipro Corporation: Geographical Revenue
Figure 43 ALung Technologies, Inc.: Key Financials
Figure 44 ALung Technologies, Inc.: Segmental Revenue
Figure 45 ALung Technologies, Inc.: Geographical Revenue
Figure 46 MAQUET Holding B.V. & Co. KG: Key Financials
Figure 47 MAQUET Holding B.V. & Co. KG: Segmental Revenue
Figure 48 MAQUET Holding B.V. & Co. KG: Geographical Revenue
Figure 49 Medos Medizintechnik AG: Key Financials
Figure 50 Medos Medizintechnik AG: Segmental Revenue
Figure 51 Medos Medizintechnik AG: Geographical Revenue
Figure 52 Terumo Cardiovascular Systems Corp: Key Financials
Figure 53 Terumo Cardiovascular Systems Corp: Segmental Revenue
Figure 54 Terumo Cardiovascular Systems Corp: Geographical Revenue
This table of content is tentative and subject to change as the research progresses.
Please Note: Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.